Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Rise at Smith & Nephew from woundcare

 

Friday 02 November 2012 01:00 GMT
Comments

The artificial knee and hip markets are sagging in Europe, but medical instruments and joints-maker Smith & Nephew managed a 10 per cent rise in trading profits to $207m (£128m) in the third quarter.

The company faces "significant challenges" in Europe, which accounts for 30 per cent of revenues, but said its woundcare business was growing at twice the rate of the rest of the market and held its outlook unchanged.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in